Dermatology and therapy
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year.
Diamant Thaçi, Akihiko Asahina, Wolf-Henning Boehncke, Alice B Gottlieb, Mark Lebwohl, Richard B Warren, Heather Edens, Barbara Ink, Rajan Bajracharya, Jason Coarse, Joseph F Merola
Published: 202510.1007/s13555-025-01599-5
Abstract
INTRODUCTION: Individuals with psoriatic arthritis (PsA) and plaque-type psoriasis and nail involvement have more severe disease and worse quality of life than those without. Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits interle…
Preview only. Read the full abstract at the source